MARKET TALK: UK Regulator Says Consider Avandia Alternatives

26th Jul 2010 19:56

2:56 (Dow Jones) UK's Medicines and Healthcare Products Regulatory Agency weighs in on debate over safety of GlaxoSmithKline's (GSK) Avandia diabetes drug. "In view of the evidence of cardiovascular risk with [Avandia] our advice to healthcare professionals is to closely observe the current contraindications, warnings and precautions and monitoring requirements, and to consider alternative treatments where appropriate," reads statement posted on agency website. GSK off a fraction at $36.41. ([email protected]) Call us at (212) 416-2180 or email [email protected] Visit the Market Talk blog at www.djnmarkettalk.com (END) Dow Jones Newswires July 26, 2010 14:56 ET (18:56 GMT)

Top Risers

Share	Price	Change
Huddled Group (HUD)	0.85	24.14%
Eurasia Mining (EUA)	2.80	19.15%
Genincode (GENI)	0.725	16%
Medpal AI (MPAL)	5.25	14.13%
Light Science Technologies (LST)	0.875	12.9%

Top Fallers

Share	Price	Change
Catenai Plc (CTAI)	0.0575	-39.47%
Petra Diamonds (PDL)	2.60	-26.14%
Focus Xplore (FOX)	0.019	-22.45%
Litigation Cap. (LIT)	0.301	-20.12%
Abrdn Property (API)	1.52	-15.56%

Top By Volume

Share	Price	Volume
Ethernity Net (ENET)	0.0019	1,922,336,250
Forgent (FORG)	0.0115	591,087,829
Premier African Minerals (PREM)	0.0044	313,776,718
Focus Xplore (FOX)	0.019	253,421,870
Bezant Resources PLC (BZT)	0.11	246,929,868

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.